ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 4.63.
| Share Price | ₹308.0 | Jun 30,2026 |
| Market Cap | ₹3,449.6 Cr | |
| Sales-TTM | ₹745.8 Cr | TTM-Consolidated Results |
| Price/Sales | 4.63x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,449.6 Cr] as on Jun 30,2026
(/) Sales [ ₹745.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.63x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '4.63 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.91x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2023 of 4.79x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ADVANCED ENZYME TECHNOLOGIES | 745.8 | 4.63 | 3,449.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.64 | 446,924.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.54 | 174,619.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.19 | 156,450.0 |
| CIPLA LTD | 28,162.6 | 4.20 | 118,361.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.36 | 113,253.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.37 | 105,169.0 |
| LUPIN LTD | 27,958.0 | 3.96 | 110,657.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.09 | 110,942.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.69 | 90,670.9 |
| LAURUS LABS LTD | 6,812.9 | 12.04 | 81,996.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.69x |
| Max industry PS | 16.54x |
| Median industry PS | 4.63x |
| Average industry PS | 7.06x |
You may also like the below Video Courses